Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2921-2924

  Tan, K C B ^a,b   Shiu, S W M ^a   Kung, A W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; THYROTROPIN; THYROXINE;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNODIFFUSION; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; BODY MASS INDEX; CARRIER PROTEINS; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GLYCOPROTEINS; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; LIPASE; LIPOPROTEINS, HDL; LIVER; MALE; THYROID DISEASES; THYROTROPIN; THYROXINE;

EID: 0031726913     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2921     Document Type: Article

References (21)

1. Nishitani H, Okamura K, Noguchi S, Inoue K, Morotomi Y, Fujishima M. 1990 Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease. Horm Metab Res. 22:490-493.
2. Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, de Moor P. 1982 Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab. 55:459-464.
3. Friis T, Pedersen LR. 1987 Senim lipids in hyper- and hypothyroidism before and after treatment. Clinica Chimica Acta. 162:155-163.
4. Muls E, Rosseneu M, Blaton V, Lesaffre E, Lamberigts G, de Moor P. 1984 Serum lipids and apolipoproteins A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J Clin Invest. 14:12-15.
5. O'Brien T, Katz K, Hodge D, Nguyen TT, Kottke BA, Hay ID. 1997 The effect of treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf). 46:17-20.
6. Verdugo C, Perrot L, Ponsin G, Valentin C, Berthezene F. 1987 Time-course of alterations of high density lipoproteins during thyroxine administration to hypothyroid women. Eur J Clin Invest. 17:313-316.
7. Agdeppa D, Macaron C, Mallik T, Schnuda ND. 1979 Plasma high density lipoprotein cholesterol concentration in thyroid disease. J Clin Endocrinol Metab. 49:726-729.
8. Kussi T, Taskinen MR, Nikkila EA. 1988 Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab. 66:61-66.
9. Pazos F, Alvarez JJ, Rubies-Prat J, Varela C, Lasuncion MA. 1995 Long term thyroid replacement therapy and levels of lipoprotein (a) and other lipoproteins. J Clin Endocrinol Metab. 80:562-566.
10. Tan KCB, Shiu SWM, Kung AWC. 1948 Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism. J Clin Endocrinol Metab. 83:140-143.
11. Tall AR. 1993 Plasma cholesteryl ester transfer protein. J Lipid Res. 34:1255-1274.
12. Kelley JL, Kruski AW. 1986 Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor. Methods Enzymol. 128:170-181.
13. Ehnholm C, Kuusi T. 1986 Preparation, characterisation, and measurement of hepatic lipase. Methods Enzymol. 129:716-738.
14. Eckel RH, Goldberg IJ, Steiner L, Yost TJ, Paterniti JR. 1988 Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes. 37:610-615.
15. Fruchart JC, Ailhaud G. 1992 Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem. 38:793-797.
16. Brinton EA, Eisenberg S, Breslow JL. 1994 Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb. 14:707-720.
17. Clay MA, Newham HH, Forte TM, Barter PJ. 1992 Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1124:52-58.
18. Busch SJ, Barnhart RL, Martin GA, et al. 1994 Human hepatic triglyceride expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem. 269:16376-16382.
19. Fan J, Wang J, Bensadoun A, et al. 1994 Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA. 91:8724-8728.
20. Staels B, Van Tol A, Chan L, Will H, Verhoeven G, Auwerx J. 1990 Alterations in thyroid status modulates apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology. 127:1144-1152.
21. Strobl W, Gorder NL, Lee YCL, Gotto AM, Patsch W. 1990 Role of thyroid hormone in apolipoprotein A-I gene expression in rat liver. J Clin Invest. 85:659-667.